STOCK TITAN

CORE Kidney, Boehringer Ingelheim and Lilly Are Turning Up the Volume on Kidney Health at the 2025 Tournament of Roses® Parade

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

CORE Kidney, Boehringer Ingelheim, and Eli Lilly (NYSE: LLY) announced their collaboration at the 2025 Tournament of Roses® Parade to raise awareness about kidney disease testing. The initiative features Pro Football Hall of Famer Brian Dawkins and emphasizes the importance of complete testing - both blood and urine tests - for kidney disease detection.

The campaign highlights alarming statistics: over 35 million U.S. adults have kidney disease, yet about 90% are unaware of their condition. Less than 20% of at-risk individuals receive both required tests. The parade float, titled 'It's In Your Hands: It Takes 2,' will feature a remixed version of Rob Base's 'It Takes Two' to promote the message of complete kidney disease screening.

CORE Kidney, Boehringer Ingelheim ed Eli Lilly (NYSE: LLY) hanno annunciato la loro collaborazione durante il Parata dei Rose® del 2025 per sensibilizzare sul test della malattia renale. L'iniziativa vede la partecipazione del Pro Football Hall of Famer Brian Dawkins e sottolinea l'importanza di effettuare test completi - sia esami del sangue che delle urine - per la diagnosi delle patologie renali.

La campagna mette in evidenza statistiche allarmanti: oltre 35 milioni di adulti negli Stati Uniti soffrono di malattie renali, ma circa 90% non sono a conoscenza della loro condizione. Meno del 20% degli individui a rischio riceve entrambi i test necessari. Il carro allegorico, intitolato 'È nelle tue mani: ci vogliono 2,' presenterà una versione remix di 'It Takes Two' di Rob Base per promuovere il messaggio di uno screening completo per le malattie renali.

CORE Kidney, Boehringer Ingelheim y Eli Lilly (NYSE: LLY) anunciaron su colaboración en el 2025 Tournament of Roses® Parade para aumentar la concienciación sobre las pruebas de enfermedades renales. La iniciativa contará con la participación del Pro Football Hall of Famer Brian Dawkins y enfatiza la importancia de realizar pruebas completas - tanto de sangre como de orina - para detectar enfermedades renales.

La campaña destaca estadísticas alarmantes: más de 35 millones de adultos en EE. UU. tienen enfermedad renal, pero aproximadamente 90% no son conscientes de su condición. Menos del 20% de las personas en riesgo recibe ambas pruebas necesarias. La carroza del desfile, titulada 'Está en tus manos: se necesitan 2,' presentará una versión remix de 'It Takes Two' de Rob Base para promover el mensaje de un cribado completo de enfermedades renales.

CORE Kidney, Boehringer Ingelheim, 그리고 Eli Lilly (NYSE: LLY)는 2025년 장미 퍼레이드에서 신장 질환 검진에 대한 인식을 높이기 위한 협력을 발표했습니다. 이 이니셔티브는 프로 풋볼 명예의 전당에 헌액된 Brian Dawkins가 참여하며, 신장 질환 발견을 위한 혈액 검사와 소변 검사의 중요성을 강조합니다.

캠페인은 심각한 통계를 강조합니다: 미국의 성인 3500만 명 이상이 신장 질환을 앓고 있지만, 그중 약 90%가 자신의 상태를 인지하지 못하고 있습니다. 위험에 처한 개인의 20% 미만이 필수 검사를 모두 받습니다. '당신의 손에 있습니다: 2명이 필요합니다'라는 제목의 퍼레이드 플로트는 Rob Base의 'It Takes Two'의 리믹스 버전을 선보여 신장 질환 검진의 중요성을 알립니다.

CORE Kidney, Boehringer Ingelheim et Eli Lilly (NYSE: LLY) ont annoncé leur collaboration lors du 2025 Tournament of Roses® Parade pour sensibiliser le public au dépistage des maladies rénales. L'initiative met en vedette le membre du Pro Football Hall of Fame Brian Dawkins et souligne l'importance d'un dépistage complet - tests sanguins et urinaires - pour détecter les maladies rénales.

La campagne met en lumière des statistiques alarmantes : plus de 35 millions d'adultes aux États-Unis souffrent de maladies rénales, mais environ 90% d'entre eux ne sont pas conscients de leur état. Moins de 20% des personnes à risque reçoivent les deux tests nécessaires. Le char de parade, intitulé 'C'est entre vos mains : il en faut 2,' présentera une version remixée de 'It Takes Two' de Rob Base afin de promouvoir le message d'un dépistage complet des maladies rénales.

CORE Kidney, Boehringer Ingelheim und Eli Lilly (NYSE: LLY) haben ihre Zusammenarbeit beim 2025 Tournament of Roses® Parade angekündigt, um das Bewusstsein für Tests auf Nierenerkrankungen zu schärfen. Die Initiative wird von Pro Football Hall of Famer Brian Dawkins unterstützt und betont die Bedeutung umfassender Tests - sowohl Blut- als auch Urintests - zur Erkennung von Nierenerkrankungen.

Die Kampagne hebt alarmierende Statistiken hervor: über 35 Millionen Erwachsene in den USA haben Nierenerkrankungen, doch etwa 90% sind sich ihrer Erkrankung nicht bewusst. Weniger als 20% der gefährdeten Personen erhalten beide erforderlichen Tests. Der Paradewagen mit dem Titel 'Es liegt in deinen Händen: Es braucht 2,' wird eine Remix-Version von Rob Bases 'It Takes Two' präsentieren, um die Botschaft von umfassenden Untersuchungen auf Nierenerkrankungen zu verbreiten.

Positive
  • None.
Negative
  • None.

Pro Football Hall of Famer Brian Dawkins joins the team to motivate those at risk for kidney disease to prioritize complete testing 

LOS ANGELES, Dec. 9, 2024 /PRNewswire/ -- CORE Kidney, a patient support and advocacy group that helps patients with kidney disease navigate their complex journey, today announced its collaboration with Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) at the 2025 Tournament of Roses® Parade. The partners have joined forces to share a powerful reminder for those at risk for kidney disease: It takes two tests – blood and urine – to ensure complete testing. Those at risk include people living with type 2 diabetes or high blood pressure, two of the main risk factors that are responsible for up to two-thirds of chronic kidney disease (CKD) cases.

"With my parents having conditions that put them at risk for CKD, I feel proud and blessed to help bring awareness to a cause that hits home for me," said Brian Dawkins, Pro Football Hall of Famer, who is helping to tackle this issue by encouraging those at risk to team up with their doctor to request complete testing for CKD. "We are providing knowledge, which becomes very powerful when applied to your health!"

Knowledge is Power
More than 35 million adults in the U.S. have kidney disease – a progressive and potentially life-threatening condition that occurs when the kidneys are damaged, which affects their ability to filter the blood and increases the risk for cardiovascular events. Despite its high prevalence, approximately 90% of people are unaware of their condition, which often has no symptoms until later, more advanced stages.

"Two of the key drivers of the low diagnostic rates are the lack of awareness and inadequate testing," explained Dr. Anjay Rastogi M.D., PhD, Director of the CORE Kidney Program and Professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA Health. "In fact, less than 20% of individuals at-risk for kidney disease receive both blood and urine tests. This collaboration with Boehringer Ingelheim, Lilly and Brian Dawkins is a tremendous opportunity to underscore the importance of not only the doctor-patient relationship but also guideline directed testing when it comes to kidney health."

Teamwork in Action
The dynamic 2025 Rose Parade float, titled "It's In Your Hands: It Takes 2," reflects a shared mission to champion kidney health and all those impacted by kidney disease. The float was designed to mirror the patient journey – from teaming up with your doctor to being embraced by the kidney health community.

"Acknowledging the control that individuals have over their own health is essential," said Andy Vicari, vice president and head of the U.S. BI/Lilly alliance at Lilly. "Through our partnership with CORE Kidney, we aim to inspire those at-risk for chronic kidney disease to take action. When people advocate for their health and collaborate with their healthcare providers, they can pave the way for a healthier future."

Remixing Kidney Health
Throughout the parade, the float – which also features a large-scale boombox on each side – will play "It Takes 2 – The Remix," an educational spin on Rob Base's 1988 classic "It Takes Two." Base rewrote the song specifically to elevate the importance of complete screening for kidney disease.

"Music is universal, making it a powerful vehicle for our message of working with your doctor to request complete testing for kidney disease," said Brian DiDonato, senior vice president, Cardiovascular, Renal and Metabolic Franchise at Boehringer Ingelheim. "We're thrilled to raise the volume of this message with our remix and partnership with Brian Dawkins, and hope that by seeing our float, those at risk feel empowered to prioritize their kidney and heart health. Because not only does complete testing – blood and urine tests – help your kidneys, but it can also uncover hidden cardiovascular risks."

This educational float can be seen in the 2025 Rose Parade® on January 1, 2025, and at the Tournament of Roses® Floatfest from January 1-3, 2025. To learn more, visit www.TestYourKidneys.com.

About the Pasadena Tournament of Roses® and Rose Parade® presented by Honda
The Pasadena Tournament of Roses® is a volunteer organization that hosts America's New Year Celebration® with the Rose Parade® presented by Honda, the Rose Bowl Game® presented by Prudential and a variety of accompanying events. The Association's 935 Members supply more than 80,000 volunteer hours, which will drive the success of the 136th Rose Parade, themed "Best Day Ever!," on Wednesday, January 1, 2025, followed by the College Football Playoff Quarterfinal at the 111th Rose Bowl Game presented by Prudential. Visit www.tournamentofroses.com, like us on Facebook and follow us on Instagram and YouTube.

About CORE Kidney
CORE Kidney is an unwavering patient support and advocacy group and a lifeline for kidney health awareness. For patients battling kidney disease, from early symptoms to late-stage conditions, CORE Kidney is dedicated to providing guidance to healing with comprehensive, integrated, and person-centered care for those suffering from this deadly disease. On a global scale, the organization aims to open the world's eyes to the prevalence and gravity of kidney ailments — while bringing recognition to the global community of brave patients facing this battle. Founded by a group of kidney patients, living kidney donors and their caregivers, who are devoted to serving those who walk the same path, CORE Kidney is on a mission to eradicate kidney disease by ensuring all patients get the care they need from the moment they suspect an issue through every step of the journey. CORE stands for the organization's core principles that serve as the guiding light in its mission: clinical excellence, outreach, research, and education. Through the organization's continued dedication to these core principles, CORE Kidney is devoted to raising the bar with various events, programs and services that directly benefit patients, living donors, families and treating professionals. CORE Kidney has cultivated a devoted community of passionate voices who empower patients to advocate for their own health and build a future where all those suffering can heal as one. This year's main event for CORE Kidney is the "It's In Your Hands: It Takes 2" float in the 2025 Rose Parade. In line with CORE Kidney's philosophy, this float represents the global focus of CORE in honoring living kidney donors and a call to action for kidney health screening.

To learn more, please visit www.corekidneyfoundation.org and/or follow CORE Kidney Foundation and CORE Kidney on socials: FacebookTwitter, and Instagram

About It Takes 2
It Takes 2 is a health initiative that aims to elevate the importance of testing and early diagnosis of chronic kidney disease (CKD) to help reduce the risk of serious complications down the road. The initiative provides tailored resources and educational content to empower adults at risk for kidney disease to work with their healthcare professional and request one simple urine test. It Takes 2 encourages healthcare professionals to proactively use two tests – eGFR blood test and UACR urine test – to get the full picture about CKD. Learn more about It Takes 2 and access helpful resources from the initiative's website at TestYourKidneys.com, as well as a version of the site for healthcare professionals at CKDtesting.com.

About Chronic Kidney Disease
Chronic kidney disease (CKD) is a progressive and potentially life-threatening condition that occurs when the kidneys are damaged by any cause that affects their ability to filter the blood. Kidney disease staging is based on kidney health and is used to guide treatment decisions. Most adults in the U.S. living with chronic kidney disease are unaware of their condition – and many do not know that they are at risk until symptoms emerge when their disease becomes advanced and irreversible kidney damage has occurred.

CKD is part of a collective group of diseases known as cardio-renal-metabolic (C-R-M) conditions that are closely intertwined and share many of the same disease-related pathways and risk factors. Dysfunction in one area of the C-R-M system may accelerate the onset of dysfunction in others. As such, people with CKD are potentially living with other C-R-M conditions, such as heart failure and type 2 diabetes. The two main causes of chronic kidney disease are diabetes and high blood pressure, which are responsible for up to two-thirds of CKD cases.

About Boehringer Ingelheim and Eli Lilly and Company
The Boehringer Ingelheim and Lilly Alliance leverages the strengths of two of the world's leading pharmaceutical companies. By joining forces, the companies demonstrate their commitment, not only to the care of people with type 2 diabetes, but also to address areas of unmet medical need like heart failure and chronic kidney disease.

About Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in Research and Development, the company focuses on developing innovative therapies in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. More than 53,500 employees serve over 130 markets to build a healthier, more sustainable, and equitable tomorrow. Discover more at www.boehringer-ingelheim.com/us.

About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news. 

P-LLY
MPR-US-103363

Media Contacts:

 

(PRNewsfoto/Boehringer Ingelheim)

 

(PRNewsfoto/Eli Lilly and Company)

 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/core-kidney-boehringer-ingelheim-and-lilly-are-turning-up-the-volume-on-kidney-health-at-the-2025-tournament-of-roses-parade-302325335.html

SOURCE Eli Lilly and Company

FAQ

What is the key message of LLY's 2025 Rose Parade kidney health campaign?

The campaign emphasizes that complete kidney disease testing requires both blood and urine tests, targeting individuals at risk, particularly those with type 2 diabetes or high blood pressure.

How many people in the US are affected by kidney disease according to LLY's campaign?

Over 35 million U.S. adults have kidney disease, with approximately 90% unaware of their condition due to the absence of early symptoms.

What percentage of at-risk individuals get complete kidney testing according to LLY?

Less than 20% of individuals at risk for kidney disease receive both blood and urine tests for complete screening.

Who is partnering with LLY for the 2025 Rose Parade kidney health initiative?

CORE Kidney, Boehringer Ingelheim, and Pro Football Hall of Famer Brian Dawkins are partnering with Eli Lilly for the kidney health awareness campaign.

Eli Lilly & Co.

NYSE:LLY

LLY Rankings

LLY Latest News

LLY Stock Data

702.58B
947.36M
0.15%
83.48%
0.73%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
INDIANAPOLIS